Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure S2 from Chemoradiotherapy and Subsequent Immunochemotherapy as Conversion Therapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase II NEXUS-1 Trial
  1. Home
  2. Publications
  3. Supplementary Figure S2 from Chemoradiotherapy and Subsequent Immunochemotherapy as Conversion Therapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase II NEXUS-1 Trial

Supplementary Figure S2 from Chemoradiotherapy and Subsequent Immunochemotherapy as Conversion Therapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase II NEXUS-1 Trial

Authors:
  • XWXin Wang
    Xin Wang
  • XKXiaozheng Kang
    Xiaozheng Kang
  • RZRuixiang Zhang
    Ruixiang Zhang
  • LXLiyan Xue
    Liyan Xue
  • JXJiaqi Xu
    Jiaqi Xu
  • XZXiaotian Zhao
    Xiaotian Zhao
  • QOQiuxiang Ou
    Qiuxiang Ou
  • NYNuo Yu
    Nuo Yu
  • GFGuojie Feng
    Guojie Feng
  • JLJiao Li
    Jiao Li
  • ZZZiyu Zheng
    Ziyu Zheng
  • XCXiankai Chen
    Xiankai Chen

Open Access
Publisher website
Google Scholar
  • 15 November 2024
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.27754969
Abstract
Supplementary Figure 2. The association between PD-L1 expression and survival in patients who received R0 resection (PD-L1 CPS <10 vs. PD-L1 CPS ≥10)
Keywords
  • GASTROINTESTINAL CANCERS
  • ESOPHAGEAL CANCER
  • IMMUNOTHERAPY
  • BIOMARKERS FOR IMMUNOTHERAPY
  • CHECKPOINT BLOCKADE
  • LIQUID BIOPSY
  • RADIATION ONCOLOGY
  • CLINICAL RADIOTHERAPEUTIC STUDIES
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.